WEDNESDAY, July 28, 2021 (HealthDay News) — An outside advisor to the U.S. Food and Drug Administration’s review of the controversial Alzheimer’s drug Aduhelm is now speaking out, arguing that the approval was based on dodgy science and involved questionable collaboration between regulators and the drug’s maker. “I’m not surprisedContinue Reading
WEDNESDAY, July 28, 2021 (HealthDay News) — The global total of people living with dementia will rise nearly three-fold by 2050, researchers say. Cases are projected to increase from an estimated 57.4 million in 2019 to an estimated 152.8 million in 2050, driven mainly by population growth and aging. ThisContinue Reading
TUESDAY, July 27, 2021 (HealthDay News) — While efforts to develop Alzheimer’s medications have so far borne little fruit, new research highlights the therapeutic promise of two non-drug tools: light and sound. According to a pair of small new studies, exposing Alzheimer’s patients to an hour a day of carefullyContinue Reading
MONDAY, July 26, 2021 (HealthDay News) — Air pollution causes you to gasp and wheeze. Smog puts strain on your hearts and inflames your lungs. Could dirty air also be costing you your brain health? A trio of new studies finds that air quality appears linked to a risk ofContinue Reading
FRIDAY, July 23, 2021 (HealthDay News) — The controversial new Alzheimer’s drug Aduhelm is creating something of a civil war in medicine, as health networks, hospitals, insurers and individual doctors weigh impending discussions with patients about whether they should take the medication. Many doctors believe the U.S. Food and DrugContinue Reading
FRIDAY, July 23, 2021 (HealthDay News) — A drug that eases hallucinations in people with Parkinson’s disease may be able to do the same for those with dementia, a new clinical trial finds. The medication, called Nuplazid (pimavanserin), is already approved in the United States for treating hallucinations and delusionsContinue Reading
WEDNESDAY, July 21, 2021 (HealthDay News) — Dementia is largely a disease of old age, but a new study finds that up to 5% of all cases are among people in the prime of their lives. Looking at 95 international studies, researchers estimated that nearly 4 million people worldwide areContinue Reading
MONDAY, July 19, 2021 (HealthDay News) — What’s better — a long life or quality of life? New research suggests that people balance both when thinking about their desired life span, and fears of suffering dementia or chronic pain in old age tend to limit how long they want toContinue Reading
THURSDAY, July 15, 2021 (HealthDay News) — Two major U.S. health systems say they will not administer the controversial new Alzheimer’s drug Aduhelm. The decisions by the Cleveland Clinic and Mount Sinai’s Health System in New York City are the latest fallout from the U.S. Food and Drug Administration’s widelyContinue Reading
THURSDAY, July 15, 2021 (HealthDay News) — An active mind in old age may delay Alzheimer’s disease by up to five years, a new study suggests. Activities like reading, writing letters, playing cards or doing puzzles may prolong brain health even for those in their 80s, researchers say. “The keyContinue Reading